Zhang Yu, Liu Fang-Mei, Li Cun-Yu, Leng Xue-Jiao, Zheng Yun-Feng, Peng Guo-Ping
School of Pharmacy, Nanjing University of Chinese Medicine Nanjing, Jiangsu, China.
National Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture Nanjing, Jiangsu, China.
Am J Transl Res. 2025 Mar 15;17(3):2178-2187. doi: 10.62347/MFBU4210. eCollection 2025.
Qingkailing Injection (QKLI) is a traditional Chinese medicine injection mainly used for sedation, heat clearing, and other treatments. However, recent clinical studies have shown a risk of pseudo-allergic reactions. The purpose of this study is to elucidate the underlying mechanism of QKLI-induced mast cell degranulation in Laboratory of Allergic Diseases 2 (LAD2) and to validate QKLI-induced activation of guinea pig IgE-independent allergic responses.
Levels of β-hexosaminidase (β-Hex), histamine (His), and complement pathway-related indicators in guinea pigs and LAD2 cells were assayed using the Enzyme-linked Immunosorbent Assay (ELISA). The release rates of β-Hex and His from LAD2 cells were measured using the o-phthalaldehyde (OPA) fluorimetric method. The antagonist for complement component 3a (C3a) receptors, SB290157 and siRNAs were used to inhibit the C3a pathway and the Mas-related G-protein-coupled receptor X2 (MRGPRX2) pathway. The MRGPRX2 pathway and its downstream proteins were detected by Western Blot (WB).
The results show that QKLI significantly increased levels of β-Hex, His, C3a, complement component 5a (C5a), and terminal complement complex C5b-9 (SC5b-9) in guinea pigs, while levels of interleukin 4 (IL-4), interleukin 13 (IL-13), and interleukin 6 (IL-6) were unaffected. The C3a receptor inhibitor SB290157 significantly reduced levels of β-Hex and His. In LAD2 cells, QKLI increased the release rates of β-Hex and His in a time-dependent manner and decreased the phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) proteins downstream of the MRGPRX2 pathway. The effective components of QKL, baicalin (BA) and geniposide (GE), individually enhance the allergic responses of LAD2 cells to some extent. However, the use of QKL is significantly superior to the individual use of its components.
We found that QKLI induced pseudoanaphylaxis via an IgE-independent response in guinea pigs and through the MRGPRX2 pathway in human LAD2 cells. Among these, the main ingredients causing pseudoallergic reactions in QKLI were BA and GE. Our research contributes to a better understanding of the mechanisms underlying drug hypersensitivity reactions (DHRs).
清开灵注射液(QKLI)是一种主要用于镇静、清热等治疗的中药注射液。然而,近期临床研究显示其存在类过敏反应风险。本研究旨在阐明QKLI在变应性疾病实验室2(LAD2)中诱导肥大细胞脱颗粒的潜在机制,并验证QKLI诱导豚鼠IgE非依赖性过敏反应的激活情况。
采用酶联免疫吸附测定法(ELISA)检测豚鼠和LAD2细胞中β-己糖胺酶(β-Hex)、组胺(His)及补体途径相关指标的水平。采用邻苯二甲醛(OPA)荧光法测定LAD2细胞中β-Hex和His的释放率。使用补体成分3a(C3a)受体拮抗剂SB290157和小干扰RNA(siRNAs)抑制C3a途径和Mas相关G蛋白偶联受体X2(MRGPRX2)途径。通过蛋白质免疫印迹法(WB)检测MRGPRX2途径及其下游蛋白。
结果显示,QKLI显著提高了豚鼠体内β-Hex、His、C3a、补体成分5a(C5a)和末端补体复合物C5b-9(SC5b-9)的水平,而白细胞介素4(IL-4)、白细胞介素13(IL-13)和白细胞介素6(IL-6)的水平未受影响。C3a受体抑制剂SB290157显著降低了β-Hex和His的水平。在LAD2细胞中,QKLI以时间依赖性方式提高了β-Hex和His的释放率,并降低了MRGPRX2途径下游细胞外信号调节激酶1/2(ERK1/2)蛋白的磷酸化水平。清开灵的有效成分黄芩苷(BA)和栀子苷(GE)在一定程度上单独增强了LAD2细胞的过敏反应。然而,使用清开灵明显优于单独使用其成分。
我们发现QKLI在豚鼠中通过IgE非依赖性反应诱导类过敏反应,并在人LAD2细胞中通过MRGPRX2途径诱导。其中,清开灵中引起类过敏反应的主要成分是BA和GE。我们的研究有助于更好地理解药物超敏反应(DHRs)的潜在机制。